Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk and Estrogen Receptor-Positive Ductal Carcinoma in Situ of Breast: an International Open-label Randomized Non-inferiority Trial

NCT04046159 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04046159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk and Estrogen Receptor-Positive Ductal Carcinoma in Situ of Breast: an International Open-label Randomized Non-inferiority Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2019
Completion date
December 31, 2025
Enrollment
810 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast ductal carcinoma in situ